Lantern Pharma Inc has announced a strategic two-phase roadmap. Phase 1 emphasizes AI-driven cancer drug development, while Phase 2 focuses on multi-disease expansion and revenue acceleration. The company has initiated hiring, expects expansion to remain cash-flow neutral, and has established an AI Center of Excellence in Bengaluru to drive innovation.
Show moreStay Ahead – Explore Now! Refex Industries Secures Major Order Worth 437.4 Million Rupees
Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.
Powered By Just Imagine
